BIOLARGO, INC. (BLGO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 1.5M 3M 4.5M Q3 '24: 4.4M Q4 '24: 3.7M Q1 '25: 3.3M Q2 '25: 2.8M Q3 '25: 1.1M Q4 '25: 617K Q1 '26: 1.1M Q2 '26: 1.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 600K 1.2M 1.8M Q3 '24: 1.7M Q4 '24: 1.8M Q1 '25: 1.5M Q2 '25: 1.4M Q3 '25: 372K Q4 '25: 128K Q1 '26: 458K Q2 '26: 675K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '24: -1.1M Q4 '24: -1.6M Q1 '25: -1.9M Q2 '25: -1.8M Q3 '25: -7.2M Q4 '25: -4M Q1 '26: -3.2M Q2 '26: -3.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '24: -1.1M Q4 '24: -1.7M Q1 '25: -1.9M Q2 '25: -1.9M Q3 '25: -7.2M Q4 '25: -4.1M Q1 '26: -3.4M Q2 '26: -4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 900K 1.8M 2.7M Q3 '24: 2.6M Q4 '24: 1.9M Q1 '25: 1.8M Q2 '25: 1.4M Q3 '25: 731K Q4 '25: 489K Q1 '26: 657K Q2 '26: 573K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '24: -1.6M Q4 '24: -1.9M Q1 '25: -1.8M Q2 '25: -2.1M Q3 '25: -2.8M Q4 '25: -1.6M Q1 '26: -2.9M Q2 '26: -3.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-1.1M -700K -350K 0 350K 700K 1.1M Q3 '11: -333.4K Q4 '11: -381.9K Q1 '18: -1M Q3 '11 Q4 '11 Q1 '18

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '24: 294.3M Q2 '24: 296.4M Q3 '24: 300.5M Q1 '25: 301.3M Q2 '25: 303.2M Q3 '25: 309M Q1 '26: 318.7M Q2 '26: 321M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.06 -0.04 -0.02 0.00 0.02 0.04 0.06 Q3 '24: -0.00 Q4 '24: -0.01 Q1 '25: -0.01 Q2 '25: -0.01 Q3 '25: -0.03 Q4 '25: -0.03 Q1 '26: -0.04 Q2 '26: -0.05 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.